Glecaprevir + pibrentasvir (ABT493 + ABT-530) for the treatment of Hepatitis C
{{output}}
Glecaprevir (formerly ABT-493, pangenotypic NS3/4A protease inhibitor) and pibrentasvir (formerly ABT-530, pangenotypic NS5A inhibitor) are second generation direct acting antivirals (DAA) for the treatment of chronic Hepatitis C (HCV). It is a fixed dose riba... ...
